Business Context and Reporting Period
This Form 8-K Current Report was filed by LifeStance Health Group, Inc. (LFST) on March 11, 2026, covering events occurring on March 10, 2026. The filing addresses Item 5.02 regarding the appointment of a new Chief Operating Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation and personnel changes.
Material Changes
The primary material change reported is the promotion of Lisa Miller to the position of Chief Operating Officer and Principal Operating Officer, effective March 10, 2026. Ms. Miller previously served as Executive Vice President, Practice Operations.
Management Commentary and Compensation Details
In connection with her appointment, Ms. Miller's compensation package includes:
- Base Salary: $485,000 annually.
- Annual Bonus: Target of 85% of base salary, contingent on performance objectives.
- Equity Award: Approximately $1,500,000 in aggregate target grant date value, consisting of time-based and performance-based restricted stock units (RSUs).
- Vesting Schedule: Both time-based and performance-based RSUs vest in equal installments over three years, subject to continued employment and achievement of performance targets.
Investor Verification Checklist
- Verify the total equity grant value of $1,500,000 and the specific performance metrics attached to the performance-based RSUs.
- Confirm the impact of this executive promotion on the company's overall operating expense structure.
- Review the 2021 Equity Incentive Plan to understand the remaining pool of shares available for future grants.